Can GLP-1 Medications Cause Pancreatitis?
FAQ-000118
Direct Answer
Yes, pancreatitis (inflammation of the pancreas) is a rare but real, documented risk associated with GLP-1 medications, listed as a warning on prescribing information for medications in this class. It's considered uncommon, but it's a genuine, serious risk worth knowing how to recognize.
Recognizing the Symptoms
The hallmark symptom is severe, persistent abdominal pain, often described as radiating from the upper abdomen through to the back, sometimes worsened after eating. This may be accompanied by nausea, vomiting, and fever. This is meaningfully different from typical, milder GLP-1-related nausea, worth taking seriously and seeking prompt medical attention if experienced.
Who May Be at Higher Risk
People with a personal history of pancreatitis, gallstones, heavy alcohol use, or very high triglyceride levels may have an elevated baseline risk, worth discussing directly with your provider before starting treatment if any of these apply to you.
What to Do If You Suspect This
Severe, persistent abdominal pain, especially radiating to the back, is not something to wait out or self-manage. Seek medical attention promptly, and stop your GLP-1 medication until you've been evaluated, following your provider's specific guidance.
Bottom Line
Pancreatitis is rare but real and serious. Knowing the specific symptom pattern, severe abdominal pain radiating to the back, is the most useful, actionable thing to take from this warning.
References
- Ozempic, Wegovy, Mounjaro, and Zepbound Prescribing Information (FDA)
Related Resources
Explore More
Explore the full GLP-1 Tracker knowledge base on DietApp.com
Get Started
Explore the GLP-1 Tracker knowledge base for accurate, sourced information on every GLP-1 medication.
About DietApp.com
DietApp.com combines evidence-based GLP-1 medication education with practical treatment tracking tools. This article is for general informational purposes and is not medical advice. Always review the full prescribing information for your specific medication and discuss any risk factors with your provider.
glp-1-pancreatitis-risk